Role of E-cadherin, alpha-, beta-, and gamma-catenins, and p120 (cell adhesion molecules) in prolactinoma behavior
- PMID: 12481018
- DOI: 10.1097/01.MP.0000039572.75188.1A
Role of E-cadherin, alpha-, beta-, and gamma-catenins, and p120 (cell adhesion molecules) in prolactinoma behavior
Abstract
E-cadherin/catenin complex regulates cellular adhesion and motility and is believed to function as an invasion suppressor system. In a number of cancers, abnormal and reduced expression of E-cadherin/catenin complex is associated with tumor invasion and metastasis. Prolactinomas show frequent invasion on the surrounding structures, despite their histologically benign nature. Furthermore, gender-based differences in endocrine and surgical findings are found in patients with prolactinoma. To understand biological factors governing prolactinoma behavior, this study analyzed the expression of E-cadherin; alpha-, beta-, and gamma-catenins; p120; and cell proliferation marker MIB-1 labeling index in 13 invasive tumors (9 in men, 4 in women), 26 noninvasive tumors (4 in men, 22 in women), and 8 normal anterior pituitaries by immunohistochemistry. Immunostaining of E-cadherin; alpha-, beta-, and gamma-catenins; and p120 showed a membranous pattern of reactivity and generally stronger in normal pituitaries than in prolactinomas. Expression of E-cadherin and beta-catenin was significantly lower in invasive than in noninvasive prolactinomas (P <.002 and P <.005, respectively), and reduced expression of E-cadherin and beta-catenin was more frequent in invasive than in noninvasive prolactinomas (P <.001 and P <.05, respectively); in contrast, gamma-catenin expression showed higher in invasive than in noninvasive prolactinomas (P <.05). Expression of E-cadherin was significantly lower in macroprolactinomas than in microprolactinomas (P <.01), and decreased expression of E-cadherin and beta-catenin predicted high MIB-1 expression (P <.05). Moreover, the expression of E-cadherin and beta-catenin was significantly lower in macroprolactinomas in men than in those in women (P <.01 and P <.02, respectively). No statistical correlations were observed between expression of alpha-catenin, p120, and clinicopathologic features. In conclusion, the reduction of E-cadherin and beta-catenin expression was related to invasiveness and proliferative status of prolactinomas and correlated with the more aggressive behavior of prolactinomas in men compared with in women.
Similar articles
-
Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors.Cancer Res. 1996 Sep 15;56(18):4154-8. Cancer Res. 1996. PMID: 8797585
-
Expression of E-cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120) in colorectal polyps.Am J Pathol. 1997 Jun;150(6):1977-84. Am J Pathol. 1997. PMID: 9176391 Free PMC article.
-
Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours.J Pathol. 2002 Feb;196(2):154-62. doi: 10.1002/path.1019. J Pathol. 2002. PMID: 11793366
-
Cadherin-catenin complex: protein interactions and their implications for cadherin function.J Cell Biochem. 1996 Jun 15;61(4):514-23. doi: 10.1002/(SICI)1097-4644(19960616)61:4%3C514::AID-JCB4%3E3.0.CO;2-R. J Cell Biochem. 1996. PMID: 8806074 Review.
-
Cell adhesion system and human cancer morphogenesis.Cancer Sci. 2003 Jul;94(7):575-81. doi: 10.1111/j.1349-7006.2003.tb01485.x. Cancer Sci. 2003. PMID: 12841864 Free PMC article. Review.
Cited by
-
Clinicopathological characterization of TSH-producing adenomas: special reference to TSH-immunoreactive but clinically non-functioning adenomas.Endocr Pathol. 2009 Winter;20(4):209-20. doi: 10.1007/s12022-009-9094-y. Endocr Pathol. 2009. PMID: 19774499
-
Genetics and proteomics of pituitary tumors.Endocrine. 2005 Oct;28(1):43-7. doi: 10.1385/ENDO:28:1:043. Endocrine. 2005. PMID: 16311409 Review.
-
The Wnt/β-catenin signaling pathway is involved in the antitumor effect of fulvestrant on rat prolactinoma MMQ cells.Tumour Biol. 2014 Jun;35(6):5121-7. doi: 10.1007/s13277-013-1571-8. Epub 2014 Mar 19. Tumour Biol. 2014. PMID: 24643679
-
N-cadherin loss in POMC-expressing cells leads to pituitary disorganization.Mol Endocrinol. 2011 Mar;25(3):482-91. doi: 10.1210/me.2010-0313. Epub 2011 Jan 27. Mol Endocrinol. 2011. PMID: 21273444 Free PMC article.
-
Epithelial-Mesenchymal Transition in the Resistance to Somatostatin Receptor Ligands in Acromegaly.Front Endocrinol (Lausanne). 2021 Mar 15;12:646210. doi: 10.3389/fendo.2021.646210. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33790868 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous